Title: South Korean Biotech Firm Embraces Cryptocurrency with Major Funding Injection
In a groundbreaking move, a South Korean biotech firm has secured a substantial funding of $183.3 million to establish a Bitcoin treasury. The Seongnam-based company, formerly known as Bridge Biotherapeutics, is set to transform into Parataxis Korea following the infusion of 25 billion won from crypto investment firm Parataxis. This strategic decision mirrors the growing…
